This is an Application Brief and does not contain a detailed Experimental section.
This application brief demonstrates analysis of naltrexone using Symmetry Shield RP8 Column.
The compounds used in this study was -
USP Tailing Factors
1. 1.05
2. 1.04
Column: |
Symmetry Shield RP8, 3.9 x 150 mm, 5 μm |
Part number: |
WAT200655 |
Mobile phase: |
100 mM Ammonium acetate, pH 5.0/acetonitrile 88:12 |
Flow rate: |
1.0 mL/min |
Injection volume: |
35 μL (500 μL eluate) |
Detection: |
UV @ 281 nm |
WA31763.106, June 2003